Clinical trial · Interventional
Prospective Clinical Investigation Comparing Standard Wound Closure Technique With Drains (Control) to Standard Wound Closure Techniques With TissuGlu® and No Drains (Test) in Mastectomy
Prospective Clinical Investigation for a Randomized, Controlled, Multicenter Non-inferiority Study Comparing Standard Wound Closure Technique With Drains (Control) to Standard Wound Closure Techniques With TissuGlu® and No Drains (Test) in Mastectomy
NCT02958449CI-TRIAL-00032261completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Comparing standard wound closure technique with drains (control) to standard wound closure techniques with TissuGlu® and no drains (test) in mastectomy
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer, Breast | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Test - Standard Closure with TissuGlu Surgical Adhesive | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Test - Standard Closure with TissuGlu Surgical Adhesive
- description
- Standard closure plus treatment with TissuGlu
- interventionNames
- Device: Test - Standard Closure with TissuGlu Surgical Adhesive
- type
- NO_INTERVENTION
- label
- Control - Standard Closure
- description
- Standard closure with no intervention
Primary outcomes (1)
- measure
- Number of Post-Operative Clinical Interventions
- timeFrame
- from day 0 to day 90
- description
- Clinical Intervention is defined as one of the following events: 1. Removal of an in-dwelling drain (As defined in the Protocol); 2. Needle aspiration to remove fluid from a Clinically-Relevant Seroma (As defined in the Protocol); 3. Invasive action to the drain or drain wound such as repositioning or re-attaching the drain retention sutures; 4. Reinsertion or insertion of a drain post operatively; 5. Surgical procedures due to wound healing complications related to wound management
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. ≥ 18 years of age; 2. Provide signed and dated informed consent form; 3. Willing to comply with all study procedures, schedules and be available for the follow-up evaluations for the duration of the study; 4. Willing to follow instructions for incision care and follow guidelines related to resumption of daily activities; 5. Agree not to schedule any additional elective surgical procedures that involve an incision until their participation in this study is complete; 6. In good general health in the opinion of the Investigator with no conditions that would significantly impact wound healing as determined by medical history, and review of recent concomitant medications; 7. Requiring a mastectomy (standard, modified, modified radical) with or without sentinel node biopsy; 8. ≤ ASA 3 - American Society of Anesthesiologists Physical Classification System Exclusion Criteria: 1. Pregnancy or lactation; 2. Known medical condition that results in compromised blood supply to tissues; 3. Known or suspected allergy or sensitivity to any test materials or reagents; 4. Any condition known to affect wound healing, such as collagen vascular disease; 5. Receiving antibiotic therapy for pre-existing condition or infection; 6. Planned immediate breast reconstruction; 7. Concurrent use of fibrin sealants or other internal wound care devices; 8. Unable to understand questions, instructions or the informed consent presentation in the language of the investigators performing the study; 9. Requiring a mastectomy with ALND (as determined at time of surgery); 10. Be participating in any conflicting medical device clinical trial within 30 days of enrollment in this study.
References
Publications (0)
Data not yet available
No reference posted for this study.